Clinical & access evidence strategy
One evidence plan that serves the clinical programme and the access case.
Shortlist it, send it over — we come back with the shape we'd actually recommend.
What clinical & access evidence strategy actually is.
A single evidence strategy that holds the clinical programme and the access case together, rather than two plans that only meet at submission. We map what the clinical programme will produce against what payers, HTA agencies and clinicians are likely to ask, and show where those diverge.
Built for teams where development decisions are still open enough to shape the access case, and for teams that have inherited a programme and need to know what the evidence will and will not support.
- Evidence strategy spanning clinical and access requirements
- Map of evidence against likely payer, HTA and clinical questions
- Divergences between regulatory and access needs made explicit
- Options and trade-offs with feasibility and sequencing
- Cross-functional working session and agreed next steps
Add the pieces you'd want and we'll build a shortlist you can review, reorder and send over. No pricing wall, no commitment — we come back with what we'd actually recommend, including anything you don't need.
Think this belongs in your scope?
Add it alongside anything else that fits, then send the shortlist over. We'll reply with the shape we'd recommend — sequence included, and the parts we think you can skip.
Build what comes next.
Whether you need growth, answers or capability, VISFO helps you move earlier and faster.